US District Court for the Northern District of West Virginia Intellectual Property Cases
Cases 41 - 50 of 200
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00201
Defendant:
Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Novo Nordisk Inc. et al v. Mylan Institutional LLC
as 1:2019cv00164
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Mylan Institutional LLC
Cause Of Action: 35 U.S.C. § 271
Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2019cv00153
Plaintiff:
Janssen Pharmaceutica N.V. and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Mylan Institutional LLC
Cause Of Action: 35 U.S.C. § 271
Subaru of America, Inc. v. A & B Sales, Inc. et al
as 5:2019cv00221
Defendant:
A & B Auto Sales, Inc. and A & B Sales, Inc.
Plaintiff:
Subaru of America, Inc.
Cause Of Action: 15 U.S.C. § 1051
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
as 1:2019cv00128
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Vifor (International) AG et al v. Mylan Laboratories Ltd.
as 1:2019cv00126
Plaintiff:
American Regent, Inc. and Vifor (International) AG
Defendant:
Mylan Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv00120
Defendant:
Mylan Pharmaceuticals Inc.
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Cause Of Action: 35 U.S.C. § 271
Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00101
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2019cv00097
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271
Keryx Biopharmaceuticals, Inc et al v. Mylan Pharmaceuticals Inc.
as 1:2019cv00040
Plaintiff:
Chen Hsing Hsu, Panion & BF Biotech, Inc. and Keryx Biopharmaceuticals, Inc
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
